Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04700904 · ClinicalTrials.gov registry record
PortionSize Study 1 Laboratory-based Evaluation)
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 43
- Enrollment target
NCT04700904: Completed study, sponsored by Pennington Biomedical Research Center.
NCT04700904 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04700904 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The objective is to test the accuracy and user satisfaction of the PortionSize™ app and the MyFitnessPal© app during laboratory controlled test meals.
Primary Outcome
The outcome variable was the difference between the criterion measure (directly weighed foods from a simulated lunch meal) and two apps: PortionSize and MyFitnessPal. The outcome measure for the PortionSize app was calculated as: energy intake values from PortionSize minus energy intake values from weighed foods. The outcome measure for the MyFitnessPal app was calculated as: energy intake values from MyFitnessPal minus energy intake values from weighed foods.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2024-12-31 |
What the finished NCT04700904 record still lists
NCT04700904 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04700904 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04700904 about?
NCT04700904 is a clinical study titled "PortionSize Study 1 Laboratory-based Evaluation)". The objective is to test the accuracy and user satisfaction of the PortionSize™ app and the MyFitnessPal© app during laboratory controlled test meals.
What is the current status of trial NCT04700904?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2021-02-10. Estimated completion is 2024-12-31.
Who is sponsoring clinical trial NCT04700904?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI